Marylyn Addo

Marylyn Addo is a Professor at the Institute for Infection Research and Vaccine Development, Universitätsklinikum Hamburg-Eppendorf (UKE). She leads critical research projects on emerging viruses and therapeutic vaccines, including TherVacB for hepatitis B and PREPARE for Ebola pre-exposure prophylaxis.

• Current Projects: Public Relations in CRC 'Emerging Viruses', PREPARE (Ebola), TherVacB (Hepatitis B)
• Research Focus: Immune response dynamics, vaccine development, and pandemic preparedness, with emphasis on SARS-CoV-2 variants, MERS-CoV, and mpox.

Key Article Trends: 15 recent publications highlight her work on viral immune evasion, vaccine-induced immunity, therapeutic immunology, zoonotic disease spread, and global health challenges in immunocompromised populations.

Leadership: Active in clinical trials, vaccine evaluation, and international collaborations, particularly in Tanzania and with the European Commission. No student lists or awards provided in available data.